Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Exact SciencesBitcoin GroupIncyteCharles River Laboratories InternationalPPD
SymbolNASDAQ:EXASOTCMKTS:BTGGFNASDAQ:INCYNYSE:CRLNASDAQ:PPD
Price Information
Current Price$130.04$62.55$82.68$323.38$46.27
52 Week RangeBuyN/AHoldBuyBuy
MarketRank™
Overall Score1.80.51.71.31.8
Analysis Score3.40.02.21.42.3
Community Score3.12.43.12.43.4
Dividend Score0.00.00.00.00.0
Ownership Score1.70.01.71.71.7
Earnings & Valuation Score0.60.01.31.31.9
Analyst Ratings
Consensus RecommendationBuyN/AHoldBuyBuy
Consensus Price Target$150.33N/A$101.50$254.71$40.10
% Upside from Price Target15.61% upsideN/A22.76% upside-21.23% downside-13.33% downside
Trade Information
Market Cap$21.99 billion$24.18 billion$18.18 billion$16.24 billion$16.21 billion
Beta1.640.260.961.12N/A
Average Volume1,753,5106001,295,769318,6601,924,412
Sales & Book Value
Annual Revenue$876.29 millionN/A$2.16 billion$2.62 billion$4.03 billion
Price / Sales25.09N/A8.426.194.02
CashflowN/AN/A$2.23 per share$12.85 per shareN/A
Price / CashN/AN/A37.0625.17N/A
Book Value$17.62 per shareN/A$12.06 per share$33.45 per shareN/A
Price / Book7.38N/A6.869.67∞
Profitability
Net Income$-83,990,000.00N/A$446.91 million$252.02 million$47.82 million
EPS($1.49)N/A$2.23$6.73$0.98
Trailing P/E RatioN/A0.00N/A53.90308.47
Forward P/E RatioN/A∞30.8536.2533.53
P/E GrowthN/AN/A0.982.191.90
Net Margins-25.27%N/A-13.62%10.68%0.21%
Return on Equity (ROE)-11.71%N/A-13.66%22.41%-11.06%
Return on Assets (ROA)-6.74%N/A-9.98%7.66%2.75%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.68%N/A0.01%1.04%N/A
Current Ratio6.35%N/A3.56%1.45%1.09%
Quick Ratio6.04%N/A3.53%1.22%1.09%
Ownership Information
Institutional Ownership Percentage90.39%N/A91.37%92.30%68.82%
Insider Ownership Percentage1.80%N/A16.10%1.90%N/A
Miscellaneous
Employees4,800271,77318,40026,000
Shares Outstanding169.09 million386.49 million219.84 million50.21 million350.43 million
Next Earnings Date5/4/2021 (Confirmed)N/A5/4/2021 (Confirmed)5/4/2021 (Confirmed)4/27/2021 (Confirmed)
OptionableOptionableNot OptionableOptionableOptionableNot Optionable
SourceHeadline
Do Traders Think PPD Inc (PPD) Can Keep Climbing Friday? - InvestorsObserverDo Traders Think PPD Inc (PPD) Can Keep Climbing Friday? - InvestorsObserver
investorsobserver.com - April 18 at 1:20 AM
Sat., Sun. games PPD, 2 players test positive - MLB.comSat., Sun. games PPD, 2 players test positive - MLB.com
mlb.com - April 18 at 1:20 AM
PPD (NASDAQ:PPD) Downgraded by TruistPPD (NASDAQ:PPD) Downgraded by Truist
americanbankingnews.com - April 17 at 4:48 PM
PPD (NASDAQ:PPD) Downgraded by Evercore ISIPPD (NASDAQ:PPD) Downgraded by Evercore ISI
americanbankingnews.com - April 17 at 4:06 PM
PPDs (PPD) "Hold" Rating Reaffirmed at Truist SecuritiesPPD's (PPD) "Hold" Rating Reaffirmed at Truist Securities
americanbankingnews.com - April 17 at 3:32 PM
PPD (NASDAQ:PPD) Cut to "Hold" at Deutsche Bank AktiengesellschaftPPD (NASDAQ:PPD) Cut to "Hold" at Deutsche Bank Aktiengesellschaft
americanbankingnews.com - April 17 at 3:32 PM
PPD (NASDAQ:PPD) Lowered to Market Perform at William BlairPPD (NASDAQ:PPD) Lowered to Market Perform at William Blair
americanbankingnews.com - April 17 at 2:52 PM
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of PPD, Inc. Buyout - Yahoo FinanceSHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of PPD, Inc. Buyout - Yahoo Finance
finance.yahoo.com - April 17 at 2:29 PM
Thermo Fisher to acquire clinical research company PPD for $17.4bn - Pharmaceutical TechnologyThermo Fisher to acquire clinical research company PPD for $17.4bn - Pharmaceutical Technology
pharmaceutical-technology.com - April 17 at 8:43 AM
PPD (NASDAQ:PPD) Sees Unusually-High Trading VolumePPD (NASDAQ:PPD) Sees Unusually-High Trading Volume
americanbankingnews.com - April 17 at 8:42 AM
SHAREHOLDER ALERT: Rigrodsky Law, PA Announces Investigation of PPD, Inc. Buyout - GlobeNewswireSHAREHOLDER ALERT: Rigrodsky Law, PA Announces Investigation of PPD, Inc. Buyout - GlobeNewswire
globenewswire.com - April 17 at 12:21 AM
PPD headquarters: A big building with a bigger impact | WilmingtonBiz - Greater Wilmington Business JournalPPD headquarters: A big building with a bigger impact | WilmingtonBiz - Greater Wilmington Business Journal
wilmingtonbiz.com - April 17 at 12:20 AM
Jaguar Holding Company II, LLC -- Moodys places PPDs ratings under review for upgrade on proposed acquisition by Thermo Fisher - Yahoo FinanceJaguar Holding Company II, LLC -- Moody's places PPD's ratings under review for upgrade on proposed acquisition by Thermo Fisher - Yahoo Finance
finance.yahoo.com - April 16 at 7:20 PM
PPD Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of PPD, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – PPD - Yahoo FinancePPD Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of PPD, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – PPD - Yahoo Finance
finance.yahoo.com - April 16 at 7:20 PM
Thermo Fisher buys contract-research company PPD for $17.4 billion - STATThermo Fisher buys contract-research company PPD for $17.4 billion - STAT
statnews.com - April 16 at 7:20 PM
NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith, LLC Reminds Investors of Investigations Related to the Following Companies: ORBCOMM Inc. (Nasdaq - ORBC), Cadence Bancorporation (NYSE - CADE), PPD, Inc. (Nasdaq - PPD)NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith, LLC Reminds Investors of Investigations Related to the Following Companies: ORBCOMM Inc. (Nasdaq - ORBC), Cadence Bancorporation (NYSE - CADE), PPD, Inc. (Nasdaq - PPD)
finance.yahoo.com - April 16 at 7:20 PM
Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization - PharmiWeb.comThermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization - PharmiWeb.com
pharmiweb.com - April 16 at 2:20 PM
PPD Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of PPD, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – PPD - Business WirePPD Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of PPD, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – PPD - Business Wire
businesswire.com - April 16 at 2:20 PM
Publishers Note: The mixed emotions of PPDs deal - Greater Wilmington Business JournalPublisher's Note: The mixed emotions of PPD's deal - Greater Wilmington Business Journal
wilmingtonbiz.com - April 16 at 2:20 PM
PPD headquarters: A big building with a bigger impact - Greater Wilmington Business JournalPPD headquarters: A big building with a bigger impact - Greater Wilmington Business Journal
wilmingtonbiz.com - April 16 at 2:20 PM
Truist Lowers PPD (NASDAQ:PPD) to HoldTruist Lowers PPD (NASDAQ:PPD) to Hold
marketbeat.com - April 16 at 12:34 PM
PPD, Inc. (PPD) Soars 6.5%: Is Further Upside Left in the Stock? - Yahoo FinancePPD, Inc. (PPD) Soars 6.5%: Is Further Upside Left in the Stock? - Yahoo Finance
finance.yahoo.com - April 16 at 9:18 AM
Waltham-based Thermo Fisher buying PPD in deal worth $17.4 billion - Boston HeraldWaltham-based Thermo Fisher buying PPD in deal worth $17.4 billion - Boston Herald
bostonherald.com - April 16 at 9:18 AM
Thermo Fisher Scientific to Acquire Contract Research Organization PPD for $17.4B - GenomeWebThermo Fisher Scientific to Acquire Contract Research Organization PPD for $17.4B - GenomeWeb
genomeweb.com - April 16 at 9:18 AM
Thermo Fisher Scientific agrees to acquire Wilmington-based PPD in $17.4 billion deal - WECTThermo Fisher Scientific agrees to acquire Wilmington-based PPD in $17.4 billion deal - WECT
wect.com - April 16 at 9:18 AM
SHAREHOLDER ALERT: WeissLaw LLP Investigates PPD, Inc. | National | troyrecord.com - Troy RecordSHAREHOLDER ALERT: WeissLaw LLP Investigates PPD, Inc. | National | troyrecord.com - Troy Record
troyrecord.com - April 16 at 9:18 AM
DateCompanyBrokerageAction
2/18/2021Exact SciencesRobert W. BairdLower Price Target
2/17/2021Exact SciencesStifel NicolausBoost Price Target
2/17/2021Exact SciencesSVB LeerinkBoost Price Target
2/17/2021Exact SciencesCowenBoost Price Target
1/27/2021Exact SciencesTruistInitiated Coverage
1/12/2021Exact SciencesCanaccord GenuityBoost Price Target
10/29/2020Exact SciencesUBS GroupDowngrade
10/28/2020Exact SciencesOppenheimerBoost Price Target
10/28/2020Exact SciencesBTIG ResearchBoost Price Target
10/28/2020Exact SciencesSmith Barney CitigroupDowngrade
10/28/2020Exact SciencesBenchmarkBoost Price Target
10/28/2020Exact SciencesCitigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellDowngrade
5/7/2020Exact SciencesBank of AmericaBoost Price Target
5/7/2020Exact SciencesCraig HallumLower Price Target
11/30/2018Bitcoin GroupJefferies Financial GroupDowngrade
4/5/2021IncyteMorgan StanleyLower Price Target
1/4/2021IncyteGuggenheimUpgrade
11/6/2020IncyteBMO Capital MarketsLower Price Target
11/6/2020IncyteRoyal Bank of CanadaLower Price Target
8/6/2020IncyteCredit Suisse GroupLower Price Target
8/4/2020IncyteMizuhoInitiated Coverage
7/28/2020IncyteJPMorgan Chase & Co.Reiterated Rating
7/24/2020IncyteWilliam BlairReiterated Rating
6/4/2020IncyteArgusBoost Price Target
2/25/2021Charles River Laboratories InternationalDeutsche Bank AktiengesellschaftBoost Price Target
11/24/2020Charles River Laboratories InternationalKeyCorpBoost Price Target
4/16/2021PPDEvercore ISIDowngrade
4/16/2021PPDTruist SecuritiesReiterated Rating
3/8/2021PPDBarclaysInitiated Coverage
(Data available from 4/18/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
Comparison Ideas:

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.